Loading organizations...
§ Venture Capital · Beijing, China
A state-backed investment fund providing capital for healthcare and life sciences in Beijing.
Beijing Medical and Health Industry Investment Fund is a state-backed government guidance fund based in Beijing, China, that provides private equity and venture capital to innovative companies operating in the healthcare and life sciences sectors. The firm targets equity investments across various specialized medical fields, including biopharmaceuticals, high-end medical devices, digital health, and cell and gene therapy. Operating with a target fund size of 20 billion RMB, or approximately $2.8 billion, the investment vehicle allocates capital directly to medical enterprises as well as to venture sub-funds. The fund was launched as part of a broader 50 billion RMB municipal initiative and is financially backed by the Beijing Municipal Government and the Beijing State-owned Capital Operation and Management Company Ltd. The organization was officially established in December 2023 by its founder, the Beijing Municipal Government.
The fund has invested in companies such as Knomix, providing tens of millions of Yuan, and was the exclusive investor for a financing round for Beijing Guanqiao Medical Technology Co., Ltd.
The Beijing Medical and Health Industry Investment Fund is described as a government-linked vehicle, associated with entities like the Daxing Industrial Investment Fund, indicating a strategic connection to public sector initiatives.
The Beijing Medical and Health Industry Investment Fund functions as an investment firm with a dedicated focus on the medical and health sector. Based in Beijing, China, the fund actively deploys capital to support the growth and innovation of companies operating within this critical industry. Its mandate involves identifying and backing enterprises that contribute to advancements in healthcare technologies and services.
The fund's investment portfolio includes notable ventures such as Knomix, which received an investment of tens of millions of Yuan. Another significant investment was made in Beijing Guanqiao Medical Technology Co., Ltd., where the Beijing Medical and Health Industry Investment Fund acted as the exclusive investor for a financing round. These investments highlight its role in providing crucial financial backing to both emerging and established players in the medical and health domain.
Operating as a government-linked vehicle, the Beijing Medical and Health Industry Investment Fund is strategically positioned within the broader Chinese venture ecosystem. This affiliation, including its association with the Daxing Industrial Investment Fund, suggests a role in supporting national initiatives, such as China's drive for self-reliance in areas like AI drug making, as evidenced by its involvement with AI drug makers.
The fund's geographic base in Beijing underscores its connection to the capital's robust medical and technological landscape. Its investment activities are geared towards strengthening the regional and national medical infrastructure, fostering a competitive environment for healthcare innovation. This localized yet impactful approach enables the fund to contribute to the strategic development of the health industry.
Through its targeted investments and strategic partnerships, the Beijing Medical and Health Industry Investment Fund aims to accelerate the commercialization of promising medical technologies and solutions. Its commitment to the sector reflects a broader effort to enhance healthcare capabilities and drive progress within the Chinese medical and health industry.
The fund has invested in companies such as Knomix, providing tens of millions of Yuan, and was the exclusive investor for a financing round for Beijing Guanqiao Medical Technology Co., Ltd.
The Beijing Medical and Health Industry Investment Fund is described as a government-linked vehicle, associated with entities like the Daxing Industrial Investment Fund, indicating a strategic connection to public sector initiatives.
Beijing Medical and Health Industry Investment Fund has 2 tracked investments across 2 companies. The latest tracked deal is $43.4M Series A in Zhiran Medical in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2026 | Zhiran Medical | $43.4M Series A | CAS Star, IDG Capital, Legend Capital | Apricot Capital, Baidu Ventures, BioVenture, Jiayin Capital, Lenovo Capital And Incubator Group (LCIG), Longzhu Capital, Sequoia Capital, Shunwei Capital, Beijing Pharmaceutical And Health Industry Investment Fund, China Life Capital, DragonBall Capital |
| Feb 10, 2026 | Transcend Vivoscope | $14.5M Series B | — | Guangdong Traditional Chinese Medicine Health Fund, Haikai Holdings Group, Tianjin Heying Haihe Brain Machine Fund, Zhongguancun Science City Science |